SecBot SecBot
6-K ·Filed Jun 3, 2026

RDPTF

Radiopharm Theranostics Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001213900-26-064446
Notable filing: 6-K
Actionable Insight • Neutral

No trading action warranted. This is a routine ASX Appendix 3H notification of option expiry with immaterial scale. Monitor the company's upcoming quarterly activities and pipeline catalysts for any material developments.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
RDPTF ▼ -50.00% at T+60d
NEUTRAL call -50.00% · α vs SPY -52.50% · entry $0.0200 → $0.0100
Entry = T+0 close
Jun 3, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.40%
$0.0200
settled 5mo ago
T+5d
0.00%
call 0.00% · α +3.82%
$0.0200
settled 5mo ago
T+20d
-50.00%
call -50.00% · α -49.00%
$0.0100
settled 4mo ago
T+60d
-50.00%
call -50.00% · α -52.50%
$0.0100
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Radiopharm Theranostics filed a Form 6-K reporting the expiry of 505,598 unquoted options (RADAN) without exercise or conversion as of May 31, 2026. This is a routine administrative notification of a minor reduction in potential dilution — the ceased securities represent less than 0.1% of total outstanding shares and options. No material financial or operational impact.

Key Facts

  • 505,598 unquoted options (RADAN) expired unexercised on May 31, 2026
  • No consideration paid by the company for the cessation
  • Total ordinary shares outstanding: 3,544,216,160; total options outstanding across all series: ~2.5 billion
  • Ceased options represent less than 0.02% of total ordinary shares outstanding

Financial Impact

Negligible — 505,598 options expired, representing less than 0.02% of the 3.54 billion ordinary shares outstanding. No cash consideration involved.

dilution

Risk Factors

  • Massive existing option overhang (~2.5 billion options vs 3.54 billion shares) could create future dilution if exercised

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-064446
Document: ea0293413-6k_radiopharm.htm0001213900-26-064446
Document: 0001213900-26-064446-index-headers.html0001213900-26-064446
Document: 0001213900-26-064446-index.html0001213900-26-064446
Document: 0001213900-26-064446.txt0001213900-26-064446
8 reports for RDPTF
Performance horizon
0% Hit rate @ T+60 0 of 4 directional calls Went positive at some point 0 of 4 best @ T+1· 0.00%Mar 27, 2026
Filters
Rows
Reports for RDPTF — sortable, filterable
TypeNow
Jun 3, 2026
20w ago
6-K
NEUTRAL ★ 2/10
$0.0200 $0.0100▼ −50.00%▼ −52.50%$0.006660 (−66.70%)
May 6, 2026
24w ago
3
NEUTRAL ★ 2/10
$0.0200 $0.0100▼ −50.00%▼ −53.83%$0.006660 (−66.70%)
Apr 23, 2026
26w ago
6-K
MIXED ★ 5/10
$0.0200 $0.0100▼ −50.00%▼ −55.02%$0.006660 (−66.70%)
Apr 16, 2026
27w ago
6-K
BULLISH ★ 7/10
$0.0200 $0.0100▼ −50.00%▼ −57.05%$0.006660 (−66.70%)
Apr 8, 2026
28w ago
6-K
BULLISH ★ 6/10
$0.0200 $0.0100▼ −50.00%▼ −60.46%$0.006660 (−66.70%)
Apr 7, 2026
29w ago
6-K
BULLISH ★ 7/10
$0.0200 $0.0100▼ −50.00%▼ −63.27%$0.006660 (−66.70%)
Apr 1, 2026
29w ago
3
NEUTRAL ★ 3/10
$0.0200 $0.0100▼ −50.00%▼ −64.16%$0.006660 (−66.70%)
Mar 27, 2026
30w ago
6-K
BULLISH ★ 7/10
$0.0200 $0.0200· 0.00%▼ −16.07%$0.006660 (−66.70%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 5, 2026